Oxidative stress and inflammation caused by reactive oxygen species (ROS) imbalance are inducer of various chronic diseases in multiple organs. The core mechanism of botanical new drug BEL-X is to inhibit ROS production resulting in reduction of the oxidative stress and the inflammation to maintain oxidative stress balance in the cells. Consequently, selected indications of botanical BEL-X focus on chronic diseases, including viral infectious chronic diseases, liver diseases, cancers, sarcopenia, and aging related chronic diseases.
Copyright (c) 2020 BELX Bio-Pharmaceutical (Taiwan) Corporation. All rights reserved